Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Breast Cancer Res Treat. 2015 Oct 22;154(2):275–286. doi: 10.1007/s10549-015-3612-z

Fig. 2.

Fig. 2

Kaplan-Meier estimates of breast cancer-free interval (BCFI) in the overall HR+/HER2- population, according to luminal A/B-like status (Status is defined by the 2013 St. Gallen Consensus: in HR+/HER2-negative disease, Luminal A-like is PgR≥20% and Ki-67<20%; B-like is either PgR<20% or Ki-67≥20%)

Abbreviations: HR+=hormone receptor positive; SE=standard error